6533b7d3fe1ef96bd1260a27
RESEARCH PRODUCT
Topical 5'-methylthioadenosine in the treatment of symptomatic chronic venous insufficiency, haemorrhoids and superficial phlebitis. A double-blind placebo-controlled trial
G. D. BompianiA. MarcialisG. PintoF. CorcioneG. CalifanoA. FlorioE. Maggioni-morattiS. ColucciD. Galatisubject
medicine.medical_specialtybusiness.industryChronic venous insufficiencySuperficial phlebitisPharmacology toxicologySigns and symptomsGeneral Medicinemedicine.diseaseSurgeryPharmacotherapyTolerabilityAnesthesiaMedicinePharmacology (medical)businessdescription
500 patients entered a randomised double-blind placebo-controlled trial designed to evaluate the efficacy and tolerability of topical 5′-methylthioadenosine (MTA) 0.5% in relieving the major signs and symptoms related to chronic venous insufficiency, superficial phlebitis and first and second degree haemorrhoids.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 1992-06-01 |